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Angiogenesis, the sprouting of new blood vessels from exist-
ing ones, is a process important both in physiological and
pathogenic conditions. During angiogenesis, endothelial cells
proliferate, migrate and organize into new, functional blood
vessels. Macrophages play an important role in this process as
they process microenvironmental cues, and directly secrete or
stimulate other cell types to secrete pro-angiogenic mediators,
including chemokines, cytokines and growth factors that together
stimulate endothelial cell proliferation, degrade the extracellu-
lar matrix (ECM), and attract leukocytes to further enhance
angiogenesis. Since macrophages are extremely plastic and can
be differently activated by various stimuli, they exert many reg-
ulatory effects on angiogenesis, although many aspects of this
regulation are still unclear.
This volume highlights several examples of macrophages-
driven regulation of angiogenesis. We begin with an introductory
review which describes the role of tumor-associated macrophages
(TAMs) in angiogenesis and lymphangiogenesis. Riabov et al.
(2014) describe the crosstalk between tumor cells and TAMs in
hypoxic and cytokine-rich microenvironment, resulting in the
induction of pro-angiogenic behavior in both cell types.
We then chose to highlight the role of the chitinases, a
family of proteins with newly discovered roles in angiogenesis.
In this review by Shao (2013), the roles and mode of action
of YKL-40/chitinase-3-like-1 (CHI3L1) are described focusing
on its angiogenic signature pertaining to tumor vasculariza-
tion and development. YKL-40 regulates tumor vascularization
mediated by endothelial cells and promotes vascular integrity
supported by smooth muscle cells. Shao also reports that while
YKL-40-induced angiogenic response in endothelial cell is VEGF-
independent, YKL-40 itself is induced when VEGF is inhibited.
Next, an original paper by Libreros et al. (2013) suggests that
increased levels of CHI3L1 produced by pulmonary macrophages
set up the pre-metastatic niche in breast cancer. CHI3L1 enhances
angiogenesis by inducing chemokines (CCL2 and CXCL2) and
MMP-9 expression, and attraction of macrophages into the lung.
The importance of CHI3L1 as a regulator of angiogenesis, as well
as possible target of treatment, is demonstrated by the addition of
chitin microparticles that can inhibit CHI3L1, chemokines and
MMP-9 production in the pre-metastatic lung.
Several pro-inflammatory mediators are long known to be
involved in angiogenesis, and the next three reviews elaborate on
these. Owen and Mohamadzadeh (2013) describe the potential
roles of M2 TAMs in modulating angiogenesis through pro-
duction of chemokines. The role of the pro-angiogenic ELR+
chemokines that attract neutrophils, and the angiostatic ELR-
chemokines, with the exception of CXCL12, are discussed in
the context of tumor progression. M1 vs. M2 secreted pro-
files of cytokines/chemokines which may play roles in immune
regulation, angiogenesis, tumor progression and metastasis are
highlighted.
Voronov et al. (2014) describe the roles of the IL-1 family of
proteins in angiogenesis, and especially IL-1β that can directly
drive endothelial cells to proliferate and generate tube-like struc-
tures, and to secrete pro-angiogenic cytokines and chemokines.
Additionally, IL-1α attracts macrophages and collaborates with
VEGF to enhance angiogenesis. Knockout mice for each of the
different members of the family help reveal that IL-1β, and to a
lesser extent IL-1α, are responsible for the pro-angiogenic effects,
and therefore IL-1β depletion could reduce angiogenesis.
The dual role of nitric oxide in tumor biology, as a cyto-
toxic factor for tumor cells, and as a pro-angiogenic factor, is
summarized by Rahat and Hemmerlein (2013). The authors cau-
tion against the common use of iNOS immunohistochemical
staining as a prognostic factor, as no correlation between sur-
vival rates, invasiveness or tumor recurrence after therapy is
found. This is due to the ability of the microenvironment (e.g.
hypoxia) to inhibit iNOS activity, even when it is highly expressed.
Furthermore, tumor cells can manipulate their own expression
of iNOS through the expression of microRNA-146a, to control
their fate and evade macrophage-induced cell death, suggesting
new possible therapeutic approaches.
Two original papers demonstrate the pro-angiogenic role
of additional, less studied proteins. Garcia-Areas et al. (2014)
suggest that semphorin 7A (SEMA7A), a member of the
semaphorin family involved in neuronal axonal guidance, is also
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a pro-angiogenic factor whose expression is increased in tumor-
bearing mice. When triggered by SEMA7A, macrophages elevate
secretion of angiogenic CXCL2/MIP-2 while silencing SEMA7A
resulted in decreased tumor angiogenesis, and lower levels of
CXCL2/MIP-2, CXCL1 and MMP-9.
Amit-Cohen et al. (2013) report that EMMPRIN, a transmem-
branal protein that is overexpressed in tumor cells and have a
pro-angiogenic activity, can induce the expression of MMP-9 and
VEGF from macrophages in a secreted form instead of mem-
branal form. Tumor cells and macrophages must be co-cultured
for this effect, emphasizing the importance of their interaction.
Secreted EMMPRIN levels were elevated through shedding-off of
the membranal protein by the activity of a serine protease that
was not yet identified.
The final paper sheds light on the clinical aspect of vascula-
ture re-growth after radiation therapy. Russell and Brown (2013)
argue that because radiation destroys endothelial cells and tumor
vasculature, tumor hypoxia is markedly increased resulting in
induction of HIF-1 and HIF-2. These factors enhance the secre-
tion of pro-angiogenic cytokines, chemokines and growth factors
and recruit bone marrow-derived monocytes and macrophages
which differentiate into TAMs and TEMs in the tumor. Thus,
targeting the infiltration process after radiation therapy may
improve the efficiency of treatment, prevent re-establishment of
new vasculature and reduce tumor recurrence.
Collectively, the articles in this topic highlight the impor-
tance and complexity of the interactions between macrophages
and tumor cells in angiogenesis. Macrophages emerge as key reg-
ulators of the process because of their ability to communicate
with tumor or stromal cells, sense the microenvironment and
respond by inducing secretion of potent pro-angiogenic medi-
ators. Some of these pro-angiogenic mediators and the triggers
for their enhanced expression and secretion are at the focus of
the current topic. Although more research is required, it is clear
that tumor cell-macrophage interactions must precede and regu-
late the secretion phase—a point that was emphasized through-
out this volume. This regulatory ability of the macrophages,
and the fact that many mediators are both pro-inflammatory
and pro-angiogenic, strongly links inflammation and angiogen-
esis together. Many inflammatory diseases, including cancer,
are characterized by enhanced angiogenesis and a prominent
macrophage component. The findings described here may be rel-
evant for understanding macrophage-angiogenesis networks and
potential therapy designs.
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